APA (7th ed.) Citation

E, Á., R, M., C, G., M, M., U, M., M, L., . . . VG, d. Y. (2026). Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL. Leukemia, 40(5), 894. https://doi.org/10.1038/s41375-026-02948-9

Chicago Style (17th ed.) Citation

E, Álvarez-Corrales, et al. "Targeting of Ibrutinib Resistance-driving Pathways by MiR-28 in ABC-DLBCL." Leukemia 40, no. 5 (2026): 894. https://doi.org/10.1038/s41375-026-02948-9.

MLA (9th ed.) Citation

E, Álvarez-Corrales, et al. "Targeting of Ibrutinib Resistance-driving Pathways by MiR-28 in ABC-DLBCL." Leukemia, vol. 40, no. 5, 2026, p. 894, https://doi.org/10.1038/s41375-026-02948-9.